{"mainPropery":{"diseaseId":180,"diseaseName":"MYH9 related thrombocytopenia","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/180/myh9-related-thrombocytopenia","synonyms":["MYH9 related disorders","Sebastian syndrome (subtype)","May-Hegglin anomaly (subtype)","Fechtner syndrome (subtype)","Epstein syndrome (subtype)","MYH9-RD","MYH9-related disease","MYH9-related disorder","MYH9-related syndrome","MYH9-related syndromic thrombocytopenia","Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss"],"synonyms-with-source":[{"name":"MYH9 related disorders","source":""},{"name":"Sebastian syndrome (subtype)","source":""},{"name":"May-Hegglin anomaly (subtype)","source":""},{"name":"Fechtner syndrome (subtype)","source":""},{"name":"Epstein syndrome (subtype)","source":""},{"name":"MYH9-RD","source":"OrphaData.Org"},{"name":"MYH9-related disease","source":"OrphaData.Org"},{"name":"MYH9-related disorder","source":"OrphaData.Org"},{"name":"MYH9-related syndrome","source":"OrphaData.Org"},{"name":"MYH9-related syndromic thrombocytopenia","source":"OrphaData.Org"},{"name":"Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss","source":"OMIM"}],"identifiers":[{"identifierType":"OMIM","identifierId":"155100"},{"identifierType":"ORPHANET","identifierId":"182050"}]},"diseaseCategories":[{"diseaseTypeId":12,"diseaseTypeName":"Blood Diseases"}],"organizations":[{"resourceID":97,"resourceName":"National Kidney Foundation","abbreviation":"","address1":"30 East 33rd Street","address2":"","address3":"","address4":"","address5":"","city":"New York","state":"NY","zip":"10016","country":"United States","phone":"212-889-2210","tty":"","tollFree":"800-622-9010","fax":"212-689-9261","email":"info@kidney.org","url":"https://www.kidney.org/","freeText":""},{"resourceID":248,"resourceName":"Platelet Disorder Support Association","abbreviation":"","address1":"8751 Brecksville Road","address2":"Suite 150","address3":"","address4":"","address5":"","city":"Cleveland","state":"OH","zip":"44141","country":"United States","phone":"440-746-9003","tty":"","tollFree":"87-PLATELET (1-877-528-3538)","fax":"844-270-1277","email":"pdsa@pdsa.org","url":"http://www.pdsa.org/","freeText":""},{"resourceID":505,"resourceName":"The Kidney Foundation of Canada","address1":"700-15 Gervais Drive","address2":"Toronto Ontario M3C 1Y8","address3":"","address4":"","address5":"","city":"","state":"","zip":"","country":"Canada","phone":"416-445-0373 ","tty":"","tollFree":"800-387-4474","fax":"416-445-7440 ","email":"kidney@kidney.on.ca","url":"http://www.kidney.on.ca"},{"resourceID":519,"resourceName":"American Kidney Fund, Inc.","abbreviation":"","address1":"11921 Rockville Pike","address2":"Suite 300","address3":"","address4":"","address5":"","city":"Rockville","state":"MD","zip":"20852","country":"United States","phone":"301-881-3052","tty":"","tollFree":"866-300-2900","fax":"","email":"helpline@kidneyfund.org","url":"http://www.kidneyfund.org","freeText":""}],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='http://www.omim.org/155100' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=DetailsSearch&Term=MYH9+related%5Bti%5D+OR+Sebastian+syndrome%5Bti%5D+OR+May-Hegglin+anomaly%5Bti%5D+OR+Fechtner+syndrome%5Bti%5D+OR+Epstein+syndrome%5Bti%5D' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss MYH9 related thrombocytopenia. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":9,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"<a href='http://www.clinicaltrials.gov/ct2/results?cond=%22MYH9+related+thrombocytopenia%22' target='_blank'>ClinicalTrials.gov</a> lists trials that are related to MYH9 related thrombocytopenia. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br />\r\n<br />\r\n<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":10,"resourceId":13,"resourceName":"MedlinePlus Genetics","descriptionText":"<a href='http://ghr.nlm.nih.gov/condition/myh9-related-disorder' target='_blank'>MedlinePlus Genetics</a> contains information on MYH9 related thrombocytopenia. This website is maintained by the National Library of Medicine.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":956,"resourceId":1653,"resourceName":"Medscape Reference May-Hegglin anomaly MYH9","descriptionText":"<a href='http://www.emedicine.com/PED/topic1383.htm ' target='_blank'>Medscape Reference</a> has information on May-Hegglin anomaly which includes information on other MYH9-related thrombocytopenias. You may need to register to view this medical reference, but registration is free.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1526,"resourceId":2158,"resourceName":"Genetic Testing Registry","descriptionText":"The <a href='http://www.ncbi.nlm.nih.gov/gtr/conditions/CN073381/' target='_blank'>Genetic Testing Registry</a> (GTR) provides information about the genetic tests for this condition. The intended audience for the GTR is health care providers and researchers. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.<br />\r\n","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Testing Resources"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"Orphanet is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=182050' target='_blank'>Orphanet</a><br />","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1537,"resourceId":2168,"resourceName":"GeneReviews","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=myh9' target='_blank'>GeneReviews</a> provides current, expert-authored, peer-reviewed, full-text articles describing the application of genetic testing to the diagnosis, management, and genetic counseling of patients with specific inherited conditions.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1539,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/ResearchTrials_Search.php?lng=EN&type_list=researchtrials_search_simple_shd&data_id=8754&Disease(s)%20concerned=Sebastian-syndrome&search=ResearchTrials_Search_Simple&ChdId=8754&ResearchTrials_ResearchTrials_Search_diseaseGroup=sebastian&ResearchTrials_ResearchTrials_Search_diseaseType=Pat&ResearchTrials_ResearchTrials_Search_country=NN&ResearchTrials_ResearchTrials_Search_GeographicType=null' target='_blank'>Orphanet</a> lists European clinical trials, research studies, and patient registries enrolling people with this condition.&nbsp;","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":1541,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/ClinicalLabs_Search.php?lng=EN&type_list=clinicalLabs_search_simple_shd&data_id=8754&Disease(s)%20concerned=Sebastian-syndrome&search=ClinicalLabs_Search_Simple&ChdId=8754&ClinicalLabs_ClinicalLabs_Search_diseaseGroup=sebastian&ClinicalLabs_ClinicalLabs_Search_diseaseType=Pat&ClinicalLabs_ClinicalLabs_Search_country=NN&ClinicalLabs_ClinicalLabs_Search_GeographicType=null&ClinicalLabs_ClinicalLabs_Search_ClinicalLabsList_Sort=QoS' target='_blank'>Orphanet</a> lists international laboratories offering diagnostic testing for this condition.","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Testing Resources"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/OMIM:605249' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2722,"resourceId":4053,"resourceName":"Patient Registry","descriptionText":"A registry supports research by collecting of information about patients that share something in common, such as being diagnosed with MYH9 related thrombocytopenia. The type of data collected can vary from registry to registry and is based on the goals and purpose of that registry. Some registries collect contact information while others collect more detailed medical information. <a href=\"https://www.nih.gov/health-information/nih-clinical-research-trials-you/list-registries\" target=\"_blank\">Learn more about registries</a>.<br />\r\n<br />\r\nRegistries for&nbsp;MYH9 related thrombocytopenia:<br />\r\n<a href='http://www.registromyh9.org/English_version/' target='_blank'>Italian Registry of MYH9-Related Disease</a><br />&nbsp;","resourceClassificationName":"Research","resourceClassificationSectionName":"Patient Registry"}],"overviewQuestion":{"questionId":2243,"questionText":"What is MYH9-related thrombocytopenia?","answerText":"<strong>MYH9-related thrombocytopenia</strong> (MYH9RD) is a genetic condition caused by mutations in the <em><a href=\"http://ghr.nlm.nih.gov/gene/MYH9\" target=\"_blank\">MYH9</a></em> gene and is characterized by large platelets and <a href=\"http://www.nhlbi.nih.gov/health/dci/Diseases/thcp/thcp_what.html\" target=\"_blank\">thrombocytopenia</a> (low number of platelets) which increases the risk for mild to serious bleeding in the body or in the skin. Young-adult onset high frequency <a href=\"http://jama.ama-assn.org/cgi/reprint/298/1/130.pdf\" target=\"_blank\">sensorineural hearing loss</a>, presenile (early) cataract, and kidney disease also variably occurs in people with this condition.[1378] This condition is inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002049.htm\" target=\"_blank\">autosomal dominant</a> fashion.&nbsp;&nbsp;<br />\r\n<br />\r\n<span style=\"font-size: 12pt;\">The following conditions, once thought to be separate, are now known to be part of MYH9RD.&nbsp;<br />\r\n<br />\r\n</span><span style=\"font-size: 12pt;\">Epstein syndrome&nbsp;<br />\r\n</span><span style=\"font-size: 12pt;\">Fechtner syndrome&nbsp;<br />\r\n</span><span style=\"font-size: 12pt;\">May-Hegglin anomaly&nbsp;<br />\r\n</span><span style=\"font-size: 12pt;\">Sebastian syndrome</span>","dateModified":"2014-01-22T09:52:00"},"basicQuestions":[{"questionId":2244,"questionText":"How is MYH9-related thrombocytopenia (MYH9RD) treated?","answerText":"There is currently no cure for MYH9-related thrombocytopenia. Measures that can be taken to prevent bleeding episodes may include platelet transfusion, desmopressin, or antifibrinolytic drug administration prior to surgery or invasive procedures, and regular dental care to prevent bleeding of the gums. People with MYH9RD should avoid drugs that inhibit platelet function or blood coagulation, activities with high risk for injury, <a href=\"http://www2.merriam-webster.com/cgi-bin/mwmednlm?book=Medical&amp;va=ototoxic\" target=\"_blank\">ototoxic</a>&nbsp;drugs, hazardous noise, nephrotoxic agents (agents that are toxic to the kidneys), <a href=\"http://www.nlm.nih.gov/medlineplus/steroids.html\" target=\"_blank\">glucocorticoids</a> (steroids) and radiation therapy. Bleeding episodes are treated with platelet transfusion and sometimes with desmopressin (this helps to shorten bleeding time in some people). People with bleeding episodes should be monitored for <a href=\"http://www.nlm.nih.gov/medlineplus/anemia.html\" target=\"_blank\">anemia</a>. Once a year urine analysis (including 2-hour protein) and a measurement of serum concentration of creatinine should be done to monitor for kidney disease. Hearing and vision evaluations are needed every three years prior to onset of hearing loss and cataracts. Kidney complications, hearing loss, and cataracts are all managed in a standard fashion.[1378]","dateModified":"2014-01-21T22:48:00","resourceClassificationName":"Treatment","references":[{"referenceId":1378,"authors":"Savoia A, Balduini CL","articleTitle":"MYH9-Related Disorders","bookWebsiteJournalTitle":"GeneReviews","date":"2011","url":"http://www.ncbi.nlm.nih.gov/books/NBK2689/","dateAccessed":"2012-04-11T00:00:00"}]}],"references":[],"relatedDiseases":[{"relatedDiseaseId":12738,"relatedDiseaseName":"Primary glomerular disease","relation":"Parent","isRare":false,"hasGardPage":false}],"gardCases":[{"caseId":24161,"abbreviatedInquiry":"How do I get rid of MYH 9 related thrombocytopenia?","caseQuestions":[{"questionId":2243,"questionText":"What is MYH9-related thrombocytopenia?","answerText":"<strong>MYH9-related thrombocytopenia</strong> (MYH9RD) is a genetic condition caused by mutations in the <em><a href=\"http://ghr.nlm.nih.gov/gene/MYH9\" target=\"_blank\">MYH9</a></em> gene and is characterized by large platelets and <a href=\"http://www.nhlbi.nih.gov/health/dci/Diseases/thcp/thcp_what.html\" target=\"_blank\">thrombocytopenia</a> (low number of platelets) which increases the risk for mild to serious bleeding in the body or in the skin. Young-adult onset high frequency <a href=\"http://jama.ama-assn.org/cgi/reprint/298/1/130.pdf\" target=\"_blank\">sensorineural hearing loss</a>, presenile (early) cataract, and kidney disease also variably occurs in people with this condition.[1378] This condition is inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002049.htm\" target=\"_blank\">autosomal dominant</a> fashion.&nbsp;&nbsp;<br />\r\n<br />\r\n<span style=\"font-size: 12pt;\">The following conditions, once thought to be separate, are now known to be part of MYH9RD.&nbsp;<br />\r\n<br />\r\n</span><span style=\"font-size: 12pt;\">Epstein syndrome&nbsp;<br />\r\n</span><span style=\"font-size: 12pt;\">Fechtner syndrome&nbsp;<br />\r\n</span><span style=\"font-size: 12pt;\">May-Hegglin anomaly&nbsp;<br />\r\n</span><span style=\"font-size: 12pt;\">Sebastian syndrome</span>","dateModified":"2014-01-22T09:52:00","references":[{"referenceId":1378,"authors":"Savoia A, Balduini CL","articleTitle":"MYH9-Related Disorders","bookWebsiteJournalTitle":"GeneReviews","date":"2011","url":"http://www.ncbi.nlm.nih.gov/books/NBK2689/","dateAccessed":"2012-04-11T00:00:00"}]},{"questionId":2244,"questionText":"How is MYH9-related thrombocytopenia (MYH9RD) treated?","answerText":"There is currently no cure for MYH9-related thrombocytopenia. Measures that can be taken to prevent bleeding episodes may include platelet transfusion, desmopressin, or antifibrinolytic drug administration prior to surgery or invasive procedures, and regular dental care to prevent bleeding of the gums. People with MYH9RD should avoid drugs that inhibit platelet function or blood coagulation, activities with high risk for injury, <a href=\"http://www2.merriam-webster.com/cgi-bin/mwmednlm?book=Medical&amp;va=ototoxic\" target=\"_blank\">ototoxic</a>&nbsp;drugs, hazardous noise, nephrotoxic agents (agents that are toxic to the kidneys), <a href=\"http://www.nlm.nih.gov/medlineplus/steroids.html\" target=\"_blank\">glucocorticoids</a> (steroids) and radiation therapy. Bleeding episodes are treated with platelet transfusion and sometimes with desmopressin (this helps to shorten bleeding time in some people). People with bleeding episodes should be monitored for <a href=\"http://www.nlm.nih.gov/medlineplus/anemia.html\" target=\"_blank\">anemia</a>. Once a year urine analysis (including 2-hour protein) and a measurement of serum concentration of creatinine should be done to monitor for kidney disease. Hearing and vision evaluations are needed every three years prior to onset of hearing loss and cataracts. Kidney complications, hearing loss, and cataracts are all managed in a standard fashion.[1378]","dateModified":"2014-01-21T22:48:00","resourceClassificationName":"Treatment","references":[{"referenceId":1378,"authors":"Savoia A, Balduini CL","articleTitle":"MYH9-Related Disorders","bookWebsiteJournalTitle":"GeneReviews","date":"2011","url":"http://www.ncbi.nlm.nih.gov/books/NBK2689/","dateAccessed":"2012-04-11T00:00:00"}]}]}],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":15541,"phenoTypeName":"Congenital thrombocytopenia","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8265,"phenoTypeName":"Bruising susceptibility","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":4319,"phenoTypeName":"Elevated hepatic transaminase","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":15538,"phenoTypeName":"Giant platelets","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":10065,"phenoTypeName":"Menorrhagia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":10054,"phenoTypeName":"Nephritis","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":10043,"phenoTypeName":"Nephropathy","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":15590,"phenoTypeName":"Neutrophil inclusion bodies","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":8487,"phenoTypeName":"Presenile cataracts","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":8879,"phenoTypeName":"Prolonged bleeding time","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":10031,"phenoTypeName":"Proteinuria","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":10015,"phenoTypeName":"Renal insufficiency","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":11337,"phenoTypeName":"Sensorineural hearing impairment","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":10371,"phenoTypeName":"Spontaneous, recurrent epistaxis","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":8988,"phenoTypeName":"Myocardial infarction","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":13082,"phenoTypeName":"Abnormal thrombosis","percentRanges":"-"},{"phenoTypeId":6539,"phenoTypeName":"Autosomal dominant inheritance","percentRanges":"-"},{"phenoTypeId":5714,"phenoTypeName":"Epistaxis","percentRanges":"-"},{"phenoTypeId":7720,"phenoTypeName":"Leukocyte inclusion bodies","percentRanges":"-"},{"phenoTypeId":15512,"phenoTypeName":"Thrombocytopenia","percentRanges":"-"}],"medicalProducts":[],"EncodedName":"MYH9_related_thrombocytopenia"}